HHV 8 encodes a latent nuclear antigen (LNA), which is the product of the viral gene orf 73. LNA is capable of forming a complex with retinoblastoma susceptibility gene product, which may be related to its oncogenic activity. HHV8 is associated with three different diseases observed in AIDS patients; kaposi's sarcoma, primary effusion lymphoma (which is a rare type of non-Hodgkin lymphoma affecting the body cavities) and multicentric Castleman's disease. HHV 8 is the likely etiological agent of Kaposis sarcoma.

Recombinant protein corresponding to the latent nuclear antigen 1 molecule of HHV8 was used as the immunogen for this HHV8 antibody.

ELISA, IF, IHC-P

Purified

0.2 mg/ml with 0.1 mg/ml BSA (US sourced), 0.05% sodium azide

Store the human HHV8 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).

This HHV8 antibody is available for research use only.

https://www.nsjbio.com/get_image.php?catalog_no=V8345-100UG&type=image1

https://www.nsjbio.com/tds-pdf/hhv8-antibody-ln53-v8345